ClinicalTrials.Veeva

Menu

CP376 OCT Exploratory Skin Study

Coloplast logo

Coloplast

Status

Completed

Conditions

Stoma Ileostomy

Treatments

Device: flat 1-piece open ostomy device

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

An explorative study investigating differences on the peristomal skin and the abdominal skin by Optimal Coherence (OCT) 12 subjects with an ileostomy using a flat 1-piece open ostomy device will be enrolled.

The investigation consists of 2 visits, a screening visit (V0) and a Baseline/test visit (V1). V1 will also terminate the study period .The total study duration will be extended to a maximum of approximately 1 week, depending on the interval between V0 and V1.

Full description

An explorative study investigating differences on the peristomal skin and the abdominal skin by Optimal Coherence (OCT)

12 subjects with an ileostomy using a flat 1-piece open ostomy device will be enrolled. Subjects will use their standard of care ostomy device as intended and remove the device at the test visit.

The investigation consists of 2 visits, a screening visit (V0) and a Baseline/test visit (V1). V1 will also terminate the study period when the OCT scan and other skin measurements has been completed. The total study duration will be extended to a maximum of approximately 1 week, depending on the interval between V0 and V1.

The OCT scans and other skin measurements (TEWL, Hydration and Erythema measurements) will be performed on the skin when the ostomy device has been removed.

Enrollment

12 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Has given written informed consent
  2. Is at least 18 years old
  3. Has full legal capacity
  4. Has an ileostomy
  5. Is using a flat 1-piece open ostomy device
  6. Have had the ileostomy for a year

Exclusion criteria

  1. Is currently receiving or have within the past two months received radio-and/or chemotherapy
  2. Is currently receiving or have within the past month received steroid treatment in the skin area used in the investigation, e.g. lotion, spray, injection or tablet
  3. Is pregnant or breastfeeding

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

12 participants in 1 patient group

OCT scan + skin measurements abdominal and peristomal skin
Other group
Description:
OCT scan + skin measurements abdominal and peristomal skin
Treatment:
Device: flat 1-piece open ostomy device

Trial contacts and locations

1

Loading...

Central trial contact

Mette Krogh

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems